Preclinical evaluation of Amblyomin-X, a Kunitz-type protease inhibitor with antitumor activity

by Durvanei A. Maria, Sonia Elisabete A.L. Will, Rosemary V. Bosch, Jean G. Souza, Juliana M. Sciani, Mauricio B. Goldfeder, Giuliana G. Rondon, Ana M. Chudzinski-Tavassi
Published 2019-01-01